These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4064287)

  • 1. Fluorescent substances in uremic and normal serum.
    Shaykh M; Bazilinski N; McCaul DS; Ahmed S; Dubin A; Musiala T; Dunea G
    Clin Chem; 1985 Dec; 31(12):1988-92. PubMed ID: 4064287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid-chromatographic profiling of endogenous fluorescent substances in sera and urine of uremic and normal subjects.
    Mabuchi H; Nakahashi H
    Clin Chem; 1983 Apr; 29(4):675-7. PubMed ID: 6831696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical elucidation and HPLC fractionation of fluorescent peptides in patients with chronic renal failure.
    Williams RH; Dubin A; Shaykh M; Musiala T; Ahmed S; Bazilinski N; Dunea G
    Adv Exp Med Biol; 1987; 223():205-13. PubMed ID: 3447437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum.
    Bourgoignie J; Klahr S; Bricker NS
    J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Middle molecules in uremic serum, urine and dialysis fluid.
    Migone L; Dall'taglio P; Buzio C
    Clin Nephrol; 1975; 3(3):82-93. PubMed ID: 1139803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialyzability and binding of digoxin-like immunoreactive factors (DLIF) with serum macromolecules in uremic patients on hemodialysis.
    Dasgupta A; Peng Y
    Life Sci; 1991; 49(22):1603-9. PubMed ID: 1943464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Middle molecules separation from uraemic serum (author's transl)].
    Dall'aglio P; Buzio C; Gardini GP; Migone L
    Ateneo Parmense Acta Biomed; 1975; 46(5):331-44. PubMed ID: 1236694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of six uremic middle molecular compounds by high performance liquid chromatography and analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Chu J; Yuan Z; Liu X; Wu Q; Mi H; He B
    Clin Chim Acta; 2001 Sep; 311(2):95-107. PubMed ID: 11566169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gel-filtration on psoriasic and uremic serum and dialysis fluid.
    Lamperi S; Buoncristiani U; Carozzi S; Cozzari M; Icardi A; Trasforini D
    Artif Organs; 1981; 4 Suppl():156-9. PubMed ID: 7295083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combining ultrafiltration, fluorescence spectroscopy and HPSEC to characterize dissolved organic matter in surface waters].
    Wang J; Wu FC; Wang LY; Liao HQ; Li W
    Huan Jing Ke Xue; 2008 Nov; 29(11):3027-34. PubMed ID: 19186797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolved organic matter with multi-peak fluorophores in landfill leachate.
    Lu F; Chang CH; Lee DJ; He PJ; Shao LM; Su A
    Chemosphere; 2009 Jan; 74(4):575-82. PubMed ID: 18986674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular weight distribution, diffusibility and comparability of middle molecular fractions prepared from normal and uremic sera by different fractionation procedures.
    Gróf J; Menyhárt J
    Nephron; 1982; 30(1):60-7. PubMed ID: 7088233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum chromatographic pattern in different dialysis strategies.
    Ringoir S; De Smet R
    Int J Artif Organs; 1978 Sep; 1(5):218-23. PubMed ID: 689764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical analytic approaches to the definition of uremic toxins.
    Furst P; Bergstrom J; Gordon A; Zimmermann L
    Ateneo Parmense Acta Biomed; 1975; 46(5):307-16. PubMed ID: 1232992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat.
    Anderstam B; Mamoun AH; Södersten P; Bergström J
    J Am Soc Nephrol; 1996 Nov; 7(11):2453-60. PubMed ID: 8959639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatomedin inhibitor in uremia.
    Phillips LS; Fusco AC; Unterman TG; del Greco F
    J Clin Endocrinol Metab; 1984 Oct; 59(4):764-72. PubMed ID: 6384255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of uremic "middle molecular" fractions by gas chromatography, mass spectrometry, isotachophoresis, and liquid chromatography.
    Schoots AC; Mikkers FE; Claessens HA; De Smet R; Van Landschoot N; Ringoir SM
    Clin Chem; 1982 Jan; 28(1):45-9. PubMed ID: 7055936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromatographic studies of uremic plasma.
    Mamdani BH; Shaykh MM; Evenson MA; Dunea G
    Int J Artif Organs; 1979 Jul; 2(4):187-91. PubMed ID: 88420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood level of middle molecular substances during uraemia and haemodialysis.
    Dzúrik R; Bozek P; Reznícek J; Oborníková A
    Proc Eur Dial Transplant Assoc; 1973; 10(0):263-70. PubMed ID: 4802412
    [No Abstract]   [Full Text] [Related]  

  • 20. [An effect of chromatographic fraction ultrafiltrate of plasma on aggregation of blood platelets in patients with chronic uremia].
    Popławski A; Myśliwiec M
    Pol Merkur Lekarski; 1996 Oct; 1(4):246-8. PubMed ID: 9156935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.